The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
Open accessAbstract
OBJECTIVES: To determine the effect of long term inhaled corticosteroids on lung function, exacerbations, and health status in patients with moderate to severe chronic obstructive pulmonary disease. DESIGN: Double blind, placebo controlled study. SETTING: Eighteen UK hospitals. PARTICIPANTS: 751 men and women aged between 40 and 75 years with mean forced expiratory volume in one second (FEV(1)) 50% of predicted normal. INTERVENTIONS: Inhaled fluticasone propionate 500 microgram twice daily from a metered dose inhaler or identical placebo. MAIN OUTCOME MEASURES: Efficacy measures: rate of decline in FEV(1) after the bronchodilator and in health status, frequency of exacerbations, respiratory withdrawals. Safety measures: morning serum cortisol concentration, incidence of adverse events. RESULTS: There was no significant difference in the annual rate of decline in FEV(1 )(P=0.16). Mean FEV(1) after bronchodilator remained significantly higher throughout the study with fluticasone propionate compared with placebo (P<0.001). Median exacerbation rate was reduced by 25% from 1.32 a year on placebo to 0.99 a year on with fluticasone propionate (P=0.026). Health status deteriorated by 3.2 units a year on placebo and 2.0 units a year on fluticasone propionate (P=0.0043). Withdrawals because of respiratory disease not related to malignancy were higher in the placebo group (25% v 19%, P=0.034). CONCLUSIONS: Fluticasone propionate 500 microgram twice daily did not affect the rate of decline in FEV(1) but did produce a small increase in FEV(1). Patients on fluticasone propionate had fewer exacerbations and a slower decline in health status. These improvements in clinical outcomes support the use of this treatment in patients with moderate to severe chronic obstructive pulmonary disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007
(2006) · Technometrics · doi:10.1198/tech.2006.s417 · Cited by 4,950
Mortality by cause for eight regions of the world: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07493-4 · Cited by 4,043
Jones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.6.1321 · Cited by 3,035
The St George's Respiratory Questionnaire
Jones, P. W., Quirk, F. H., & Baveystock, C. M. (1991) · Respiratory Medicine · doi:10.1016/s0954-6111(06)80166-6 · Cited by 2,683
Courgeau, D., & Goldstein, H. (1997) · Population (French Edition) · doi:10.2307/1534624 · Cited by 2,562
The natural history of chronic airflow obstruction.
Fletcher, C., & Peto, R. (1977) · BMJ · doi:10.1136/bmj.1.6077.1645 · Cited by 2,370
Standardization of Spirometry—1987 Update
(1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.5.1285 · Cited by 2,315
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., PAUL, E. A., BESTALL, J. C., JEFFRIES, D. J., & WEDZICHA, J. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709032 · Cited by 2,312
Anthonisen, N. R. (1994) · JAMA · doi:10.1001/jama.1994.03520190043033 · Cited by 1,341
Pauwels, R. A., Löfdahl, C.-G., Laitinen, L. A., Schouten, J. P., Postma, D. S., Pride, N. B., & Ohlsson, S. V. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402503 · Cited by 1,074
Vestbo, J., Søorensen, T., Lange, P., Brix, A., Torre, P., & Viskum, K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10019-3 · Cited by 816
Ployhart, R. E. (2014) · Wiley StatsRef: Statistics Reference Online · doi:10.1002/9781118445112.stat06437 · Cited by 801
The natural history of chronic bronchitis and emphysema
Little, G. M. (1979) · Resuscitation · doi:10.1016/0300-9572(79)90018-2 · Cited by 600
Brightling, C. E., Monteiro, W., Ward, R., Parker, D., Morgan, M. D., Wardlaw, A. J., & Pavord, I. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02872-5 · Cited by 595
Paggiaro, P. L., Dahle, R., Bakran, I., Frith, L., Hollingworth, K., & Efthimiou, J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)03471-5 · Cited by 508
Meecham Jones, D. J., Paul, E. A., Jones, P. W., & Wedzicha, J. A. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.2.7633704 · Cited by 479
Stanescu, D., Sanna, A., Veriter, C., Kostianev, S., Calcagni, P. G., Fabbri, L. M., & Maestrelli, P. (1996) · Thorax · doi:10.1136/thx.51.3.267 · Cited by 462
Sputum Eosinophilia Predicts Benefit from Prednisone in Smokers with Chronic Obstructive Bronchitis
PIZZICHINI, E., PIZZICHINI, M. M. M., GIBSON, P., PARAMESWARAN, K., GLEICH, G. J., BERMAN, L., DOLOVICH, J., & HARGREAVE, F. E. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.5.9804028 · Cited by 399
Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease
Osman, I. M., Godden, D. J., Friend, J. A., Legge, J. S., & Douglas, J. G. (1997) · Thorax · doi:10.1136/thx.52.1.67 · Cited by 352
Structural and inflammatory changes in COPD: a comparison with asthma.
Jeffery, P. K. (1998) · Thorax · doi:10.1136/thx.53.2.129 · Cited by 328
Tashkin, D. P., Altose, M. D., Connett, J. E., Kanner, R. E., Lee, W. W., & Wise, R. A. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.6.8665038 · Cited by 314
Spirometry in the Lung Health Study: 1. Methods and Quality Control
Enright, P. L., Johnson, L. R., Connett, J. E., Voelker, H., & Buist, A. S. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/143.6.1215 · Cited by 296
Another smoking hazard: raised serum IgE concentration and increased risk of occupational allergy.
Zetterstrom, O., Osterman, K., Machado, L., & Johansson, S. G. (1981) · BMJ · doi:10.1136/bmj.283.6301.1215 · Cited by 282
PAPI, A., ROMAGNOLI, M., BARALDO, S., BRACCIONI, F., GUZZINATI, I., SAETTA, M., CIACCIA, A., & FABBRI, L. M. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.9910112 · Cited by 280
Susceptibility Genes for Rapid Decline of Lung Function in the Lung Health Study
SANDFORD, A. J., CHAGANI, T., WEIR, T. D., CONNETT, J. E., ANTHONISEN, N. R., & PARÉ, P. D. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.2.2006158 · Cited by 260
Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review
Poole, P. J., & Black, P. N. (2001) · BMJ · doi:10.1136/bmj.322.7297.1271 · Cited by 256
Orie, N. G. M. (1961) · Medical Entomology and Zoology · Cited by 243
Callahan, C. M., Dittus, R. S., & Katz, B. P. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-3-216 · Cited by 233
O'connor, G. T., Sparrow, D., & Weiss, S. T. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.1.225 · Cited by 217
Dompeling, E., van Schayck, C. P., van Grunsven, P. M., van Herwaarden, C. L. A., Akkermans, R., Molema, J., Folgering, H., & van Weel, C. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-10-199305150-00003 · Cited by 211
van Grunsven, P. M., van Schayck, C. P., Derenne, J. P., Kerstjens, H. A. M., Renkema, T. E. J., Postma, D. S., Similowski, T., Akkermans, R. P., Jong, P. C. M. P.-D., Dekhuijzen, P. N. R., et al. (1999) · Thorax · doi:10.1136/thx.54.1.7 · Cited by 167
Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1.
Rijcken, B., Schouten, J. P., Xu, X., Rosner, B., & Weiss, S. T. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.5.7735588 · Cited by 162
Jarad, N. A., Wedzicha, J. A., Burge, P. S., & Calverley, P. M. A. (1999) · Respiratory Medicine · doi:10.1016/s0954-6111(99)90001-x · Cited by 160
Self-citationPostma, D. S., de Vries, K., Koëter, G. H., & SLUITER, H. J. (1986) · PubMed · doi:10.1164/arrd.1986.134.2.276 · Cited by 144
O’Connor, G. T., Sparrow, D., & Weiss, S. T. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.1.7599868 · Cited by 135
Pharmacokinetics of Triamcinolone Acetonide After Intravenous, Oral, and Inhaled Administration
Derendorf, H., Hochhaus, G., Rohatagi, S., Möllmann, H., Barth, J., Sourgens, H., & Erdmann, M. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04064.x · Cited by 112
Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction?
Postma, D. S., Peters, I., Steenhuis, E. J., & Sluiter, H. (1988) · European Respiratory Journal · doi:10.1183/09031936.93.01010022 · Cited by 104
International Comparisons in COPD Mortality
Thom, T. J. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.3_pt_2.s27 · Cited by 100
Smoking, allergy, and the differential white blood cell count.
Taylor, R. G., Gross, E., Joyce, H., Holland, F., & Pride, N. B. (1985) · Thorax · doi:10.1136/thx.40.1.17 · Cited by 98
Allergy markers in respiratory epidemiology
Baldacci, S., Omenaas, E. R., & Oryszczyn, M. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.17407730 · Cited by 86
Li, J. T. C., Ford, L. B., Chervinsky, P., Weisberg, S. C., Kellerman, D. J., Faulkner, K. G., Herje, N. E., Hamedani, A. G., Harding, S. M., & Shah, T. P. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70180-6 · Cited by 80
Skin Test Reactivity to Common Aeroallergens and Decline of Lung Function. The Normative Aging Study
Gottlieb, D. J., Sparrow, D., O’Connor, G. T., & Weiss, S. T. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.2.8564098 · Cited by 75
CALVERLEY, P. M. A. (2000) · Thorax · doi:10.1136/thorax.55.1.78 · Cited by 47
Lim, T. K., Taylor, R. G., Watson, A., et al. (1988) · Thorax · doi:10.1136/thx.43.8.599 · Cited by 34
Clinical evidence: Stable chronic obstructive pulmonary disease
Kerstjens, H. A. M. (1999) · BMJ · doi:10.1136/bmj.319.7208.495 · Cited by 27
Cited by
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Global Initiative for Chronic Obstructive Lung Disease
Gerald, L. B., & Bailey, W. C. (2002) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200207000-00004 · Cited by 5,830
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
Celli, B. R., MacNee, W., Agusti, A., Anzueto, A., Berg, B., Buist, A. S., Calverley, P. M. A., Chavannes, N., Dillard, T., Fahy, B., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,421
Metadata
- Authors
- Burge, P. S.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2000-05-13
- Volume
- 320
- Issue
- 7245
- Pages
- 1297-1303
- ISSN
- 0959-8138 (ISSN-L)
- OpenAlex
- W2133119676
- Cited by
- 1,675
- References
- 46
- FWCI
- 84.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.